Edition:
United States

Regenxbio Inc (RGNX.OQ)

RGNX.OQ on NASDAQ Stock Exchange Global Select Market

71.20USD
22 Jun 2018
Change (% chg)

$3.65 (+5.40%)
Prev Close
$67.55
Open
$67.60
Day's High
$71.25
Day's Low
$64.75
Volume
639,602
Avg. Vol
177,985
52-wk High
$71.25
52-wk Low
$17.60

Select another date:

Mon, Jun 11 2018

BRIEF-Regenxbio Receives $100 Mln Accelerated License Payment

* REGENXBIO RECEIVES $100 MILLION ACCELERATED LICENSE PAYMENT DUE TO ACQUISITION OF AVEXIS BY NOVARTIS

BRIEF-Regenxbio Reports Q1 Earnings Per Share $3.04

* REGENXBIO REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND RECENT OPERATIONAL HIGHLIGHTS

BRIEF-Regenxbio Inc Q4 Loss Per Share ‍$0.51​

* REGENXBIO REPORTS FOURTH QUARTER AND FULL-YEAR 2017 FINANCIAL RESULTS AND RECENT OPERATIONAL HIGHLIGHTS

BRIEF-Regenxbio Enters Strategic Partnership With Fujifilm Diosynth Biotechnologies

* REGENXBIO ENHANCES GENE THERAPY MANUFACTURING CAPABILITIES BY ENTERING INTO STRATEGIC PARTNERSHIP WITH FUJIFILM DIOSYNTH BIOTECHNOLOGIES

BRIEF-Regenxbio And Avexis Announce Expansion Of Relationship For Spinal Muscular Atrophy treatments

* REGENXBIO AND AVEXIS ANNOUNCE EXPANSION OF RELATIONSHIP THROUGH AMENDED LICENSE AGREEMENT FOR THE DEVELOPMENT AND COMMERCIALIZATION OF TREATMENTS FOR SPINAL MUSCULAR ATROPHY

BRIEF-Regenxbio Provides Year-End 2017 Corporate Update

* - ‍ANTICIPATE INITIATING DOSING IN CLINICAL TRIALS FOR MPS I AND MPS II IN FIRST HALF 2018​

Select another date: